Dr Mehmood Khan, CEO of Hevolution Foundation, a healthcare and longevity trailblazer, called on the regional healthcare community to proactively tackle future challenges arising from an ageing population.
His remarks, delivered at the opening of Arab Health’s Future Health Summit at the Museum of the Future, emphasized the need for an all-of-society approach to achieve healthy longevity.
Dr. Khan emphasized the significance of addressing the challenge of poor healthspan, the period people spend in poor health, versus lifespan, the duration of longer life.
He revealed the global average of years spent in poor health is 9.7 years, stressing the need to ensure those in later life remain independent, cognitive, functional, and contribute to their communities.
Rethinking Public Health for Aging Societies: Dr. Mehmood Khan Advocates Proactive Measures at Arab Health’s Future Health Summit
Speaking at the session Bridging the Gap Between Lifespan and Healthspan, Dr Khan said: “The MENA population most at risk for noncommunicable diseases (NCDs) is those over 60 years. Adult obesity is becoming a significant issue and risk factor, and cardiovascular disease, cancer, and diabetes represent up to one-third of the disease burden in the region. Because the population is relatively young, now is the time to rethink our public health approach to address these future challenges.
He added, “If we can intervene in ageing, society would reap substantial benefits. From reactive amelioration to proactive prevention, we can diminish vulnerability to future disability for the ageing population, reduce the infirmities of old age, increase individual productivity, and decrease healthcare costs globally. Compressing morbidity by 12 months could generate $40 trillion annually in healthcare cost savings and productivity increases.”
Other speakers at the invite-only event for C-suite executives from the healthcare industry and government officials included Shaista Asif, Group Chief Executive Officer of PureHealth and Dr Michael Ringel, Managing Director of Boston Consulting Group, who discussed The Opportunity for Investment in Longevity Biotech.
Panellists for the discussion on “The Longevity Economy: Navigating the Next Frontier” included
- Dr Yoshiki Sawa, Professor at Osaka University and Advisor to CiRA at Kyoto University
- Prof Dr Evelyne Bischof, Founding Vice President of Healthy Longevity Medicine Society and Chair of the Scientific Advisory Board at Longevity Science Foundation
- Marc P. Bernegger, Founding Partner of Maximon and Longevity Investors Conference
Closing remarks were made by Dr Fatima Al Kaabi, Director General, Emirates Drug Establishment and Executive Director of Abu Dhabi Bone Marrow Transplant Program at Abu Dhabi Stem Cells, a PureHealth subsidiary. Center Vice-Chair,
Arab Health concluded on Thursday, 1 February, at 5 pm.
